Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Глобальное, региональное и национальное бремя болезни Паркинсона, 1990–2016 гг.: систематический анализ в рамках исследования «Глобальное бремя болезней» 2016 года
2018-10-01
SCID: 54.1/zbapftpn
Discuss with AI
Global Burden of DiseaseParkinson's diseaseSocio-demographic Indexage-standardised prevalencedisability-adjusted life-years
Figures from the paper
Abstract (AI)
BACKGROUND: Neurological disorders are now the leading source of disability globally, and ageing is increasing the burden of neurodegenerative disorders, including Parkinson's disease. We aimed to determine the global burden of Parkinson's disease between 1990 and 2016 to identify trends and to enable appropriate public health, medical, and scientific responses. METHODS: Through a systematic analysis of epidemiological studies, we estimated global, regional, and country-specific prevalence and years of life lived with disability for Parkinson's disease from 1990 to 2016. We estimated the proportion of mild, moderate, and severe Parkinson's disease on the basis of studies that used the Hoehn and Yahr scale and assigned disability weights to each level. We jointly modelled prevalence and excess mortality risk in a natural history model to derive estimates of deaths due to Parkinson's disease. Death counts were multiplied by values from the Global Burden of Disease study's standard life expectancy to compute years of life lost. Disability-adjusted life-years (DALYs) were computed as the sum of years lived with disability and years of life lost. We also analysed results based on the Socio-demographic Index, a compound measure of income per capita, education, and fertility. FINDINGS: In 2016, 6·1 million (95% uncertainty interval [UI] 5·0-7·3) individuals had Parkinson's disease globally, compared with 2·5 million (2·0-3·0) in 1990. This increase was not solely due to increasing numbers of older people, because age-standardised prevalence rates increased by 21·7% (95% UI 18·1-25·3) over the same period (compared with an increase of 74·3%, 95% UI 69·2-79·6, for crude prevalence rates). Parkinson's disease caused 3·2 million (95% UI 2·6-4·0) DALYs and 211 296 deaths (95% UI 167 771-265 160) in 2016. The male-to-female ratios of age-standardised prevalence rates were similar in 2016 (1·40, 95% UI 1·36-1·43) and 1990 (1·37, 1·34-1·40). From 1990 to 2016, age-standardised prevalence, DALY rates, and death rates increased for all global burden of disease regions except for southern Latin America, eastern Europe, and Oceania. In addition, age-standardised DALY rates generally increased across the Socio-demographic Index. INTERPRETATION: Over the past generation, the global burden of Parkinson's disease has more than doubled as a result of increasing numbers of older people, with potential contributions from longer disease duration and environmental factors. Demographic and potentially other factors are poised to increase the future burden of Parkinson's disease substantially. FUNDING: Bill & Melinda Gates Foundation.
Key Findings
1
Global Parkinson’s disease prevalence increased from 2.5 million in 1990 to 6.1 million in 2016.
2
Parkinson’s disease caused 3.2 million DALYs and 211,296 deaths globally in 2016.
3
The increase exceeded population ageing effects: age-standardised prevalence rose 21.7%, while crude prevalence increased 74.3%.
4
The male-to-female ratio of age-standardised prevalence remained similar, increasing slightly from 1.37 in 1990 to 1.40 in 2016.
5
The study estimated prevalence, disability, deaths, years of life lost, and DALYs globally, regionally, nationally, and across Socio-demographic Index levels.
Research Object
Parkinson's disease
Research Subject
Global, regional, and national burden of Parkinson's disease from 1990 to 2016, including prevalence, disability, mortality, and DALYs
Publication Details
Publication Date
2018-10-01
Journal
Publisher
ISSN
Cited by
2819
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai4
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 20152016
Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 20162019
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 20162017
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 20162017
Cited by6
Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 20162019
Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 20212024
The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 20172020
Artificial intelligence within the interplay between natural and artificial computation: Advances in data science, trends and applications2020
Neuroprotective Effects of Coffee Bioactive Compounds: A Review2020
Nose-to-brain drug delivery: from bench to bedside2025